PMV Pharmaceuticals, Inc. Share Price & Technical Analysis
PMVP · $1.26 (-1.56%)
Healthcare / Biotechnology
$1.26
-1.56%
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United States. It develops rezatapopt, a selective structural corrector of p53 Y220C mutations in Phase 2 clinical trials for tumor agnostic diseases. The company was formerly known as PJ Pharmaceuticals, Inc. and…
Price chart
Seasonality
May has 1 positive and 3 negative years (last 5 years shown)
-7% return in May, 2% avg return in past 3 year May month.
24% return in 2026, -20% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -15% | 55% | -25% | 17% | -7% | – | – | – | – | – | – | – | 24% |
| 25 | -7% | 0% | -21% | -9% | -10% | 22% | 40% | 0% | 0% | 0% | -7% | -8% | 0% |
| 24 | -42% | 6% | -6% | 6% | 0% | -11% | 6% | -6% | 0% | 7% | 0% | -6% | -46% |
| 23 | -7% | -12% | -33% | -2% | 15% | 17% | 3% | 11% | -16% | -75% | 53% | 35% | -12% |
| 22 | -30% | -2% | 32% | -30% | -18% | 19% | 5% | -7% | -14% | 0% | -19% | -12% | -77% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Weak
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United States. It develops rezatapopt, a selective structural corrector of p53 Y220C mutations in Phase 2 clinical trials for tumor agnostic diseases. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Princeton, New Jersey.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$77.86M
P/E ratio
—
52W high
$1.88
52W low
$0.85
Volume
1,63,288
Beta
1.41
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is PMV Pharmaceuticals, Inc. share price today?
- PMV Pharmaceuticals, Inc. (PMVP) last traded around $1.26 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does PMVP have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for PMVP. Download the app for real-time alerts.
- How can I analyze PMV Pharmaceuticals, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.